Yubo International Biotech Limited reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 0.098303 million compared to USD 0.194459 million a year ago. Net loss was USD 0.336584 million compared to USD 0.304712 million a year ago.
For the nine months, sales was USD 0.912103 million compared to USD 0.471148 million a year ago. Net loss was USD 1.15 million compared to USD 0.430301 million a year ago. Basic loss per share from continuing operations was USD 0.01.